Variant report
Variant | esv3330847 |
---|---|
Chromosome Location | chr8:50448349-50450497 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186024700 | chr8:50448369-50448370 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535710738 | chr8:50448395-50448396 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549782040 | chr8:50448421-50448422 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562391731 | chr8:50448424-50448425 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191698727 | chr8:50448428-50448429 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557423825 | chr8:50448469-50448470 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201820454 | chr8:50448525-50448526 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4873109 | chr8:50448529-50448530 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374189725 | chr8:50448637-50448638 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377194972 | chr8:50448647-50448648 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539584420 | chr8:50448722-50448723 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146047787 | chr8:50448753-50448754 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540017699 | chr8:50448785-50448786 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527913919 | chr8:50448942-50448943 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138816816 | chr8:50448959-50448960 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183936760 | chr8:50449111-50449112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537073464 | chr8:50449119-50449120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13258357 | chr8:50449156-50449157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs13265776 | chr8:50449158-50449159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs71235738 | chr8:50449178-50449179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11781743 | chr8:50449202-50449203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11782497 | chr8:50449204-50449205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs58087139 | chr8:50449232-50449233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13258425 | chr8:50449248-50449249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs13265852 | chr8:50449250-50449251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs13258636 | chr8:50449256-50449257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13266075 | chr8:50449258-50449259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10679641 | chr8:50449264-50449265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534995130 | chr8:50449371-50449372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555313238 | chr8:50449385-50449386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34532858 | chr8:50449396-50449397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568025343 | chr8:50449435-50449436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535343272 | chr8:50449450-50449451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188838100 | chr8:50449460-50449461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554033222 | chr8:50449581-50449582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572188965 | chr8:50449583-50449584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115571010 | chr8:50449587-50449588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182216050 | chr8:50449598-50449599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61660606 | chr8:50449623-50449624 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs191647380 | chr8:50449641-50449642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561624327 | chr8:50449689-50449690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529590835 | chr8:50449707-50449708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541405619 | chr8:50449716-50449717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs559983131 | chr8:50449723-50449724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533394529 | chr8:50449756-50449757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376621806 | chr8:50449793-50449794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374521231 | chr8:50449806-50449807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550150546 | chr8:50449836-50449837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184117299 | chr8:50449844-50449845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570077990 | chr8:50449920-50449921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:50447400-50448800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr8:50448800-50449000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr8:50449000-50450200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr8:50450200-50454200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |